title: Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
abstract: During the last two decades, substantial efforts have been made towards the development and international acceptance of alternative methods to safety studies using laboratory animals. In the EU, challenging timelines for phasing out of many standard tests using laboratory animals were established in the seventh Amending Directive 2003/15/EC to Cosmetics Directive 76/768/EEC. In continuation of this policy, the new European Chemicals Legislation (REACH) favours alternative methods to conventional in vivo testing, if validated and appropriate. Even alternative methods in the status of prevalidation or validation, but without scientific or regulatory acceptance may be used under certain conditions. Considerable progress in the establishment of alternative methods has been made in some fields, in particular with respect to methods predicting local toxic effects and genotoxicity. In more complex important fields of safety and risk assessment such as systemic single and repeated dose toxicity, toxicokinetics, sensitisation, reproductive toxicity and carcinogenicity, it is expected that the development and validation of in silico methods, testing batteries (in vitro and in silico) and tiered testing systems will have to overcome many scientific and regulatory obstacles which makes it extremely difficult to predict the outcome and the time needed. The main reasons are the complexity and limited knowledge of the biological processes involved on one hand and the long time frame until validation and regulatory acceptance of an alternative method on the other. New approaches in safety testing and evaluation using "Integrated Testing Strategies" (ITS) (including combinations of existing data, the use of chemical categories/grouping, in vitro tests and QSAR) that have not been validated or not gained wide acceptance in the scientific community and by regulatory authorities will need a thorough justification of their appropriateness for a given purpose. This requires the availability of knowledge and experience of experts in toxicology. The challenging deadlines for phasing out of in vivo tests in the Cosmetics Amending Directive 2003/15/EC appear unrealistic. Likewise, we expect that the application of validated alternative methods will only have a small or moderate impact on the reduction of in vivo tests under the regimen of REACH, provided that at least the same level of protection of human health as in the past is envisaged. As a consequence, under safety aspects, it appears wise to consider established in vivo tests to be indispensable as basic tools for hazard and risk assessment with respect to systemic single and repeated dose toxicity, sensitisation, carcinogenicity and reproductive toxicity, especially regarding quantitative aspects of risk assessment such as NOAELs, LOAELs and health-related limit values derived from them. Based on the overall evaluation in this review, the authors are of the opinion that in the short- and mid-term, the strategy of the development of alternative methods should be more directed towards the refinement or reduction of in vivo tests. The lessons learnt during these efforts will provide a substantial contribution towards the replacement initiatives in the long-term.
authors.affiliation: Dr Lilienblum Consulting Toxicology LiCoTox, Hemmingen/Han, Germany. werner.lilienblum@t-online.de
authors.forename: W
authors.initials: W
authors.lastname: Lilienblum
authors.forename: W
authors.initials: W
authors.lastname: Dekant
authors.forename: H
authors.initials: H
authors.lastname: Foth
authors.forename: T
authors.initials: T
authors.lastname: Gebel
authors.forename: J G
authors.initials: JG
authors.lastname: Hengstler
authors.forename: R
authors.initials: R
authors.lastname: Kahl
authors.forename: P-J
authors.initials: PJ
authors.lastname: Kramer
authors.forename: H
authors.initials: H
authors.lastname: Schweinfurth
authors.forename: K-M
authors.initials: KM
authors.lastname: Wollin
mesh_terms: D000826:Animal Testing Alternatives / Q000331:legislation & jurisprudence*; D000827:Animal Welfare / Q000331:legislation & jurisprudence; D000818:Animals; D000830:Animals, Laboratory; D005060:Europe; D017408:Guidelines as Topic; D006801:Humans; D018570:Risk Assessment; D012449:Safety / Q000331:legislation & jurisprudence; D018675:Toxicity Tests / Q000379:methods